Skip to main content

Drug Recalls

Featured Article
Apotex Corp is voluntarily recalling 55,620 bottles of guanfacine extended-release tablets, 2 mg, because trace amounts of the schizophrenia drug quetiapine fumarate were found in products from one…
Alembic Pharmaceuticals Limited is recalling more than 12,000 bottles of telmisartan tablets after a bottle labelled to contain 20-mg tablets was found to contain 40-mg tablets.


A Class II recall is active for a prescription analgesic injection used during anesthetic periods, premedication, induction and maintenance, and in the immediate postoperative period.
Doug Zurawski, PharmD, senior vice president, Clinical Strategy, Kit Check, discusses the results of a recent hospital pharmacy survey and explains the major impact drug shortages have on hospitals, and why hospital pharmacy leaders need to begin to…
In response to the recent FDA announcement to pull all ranitidine products from the market, Van Coble, BS Pharm, retired pharmacist, expresses his concerns with the recall as well as NDMA contamination. 
Older patients account for about a third of all inpatient care, but they are involved in approximately half of hospitalizations marred by adverse drug events.

Interactive Features

Which narcotic pain medication—used to treat moderate to severe pain—has been recalled in the last two FDA Enforcement Reports?
Peter Pitts, former associate commissioner at the US FDA and president of the Center for Medicine in the Public Interest, discusses why the FDA pulled a large quantity of a blood pressure drugs off the market and why it is important to understand.…
Back to Top